Imexpharm Corporation (HOSE: IMP)

Imexpharm Revenue

Imexpharm had revenue of 544.74B VND in the quarter ending September 30, 2024, with 16.67% growth. This brings the company's revenue in the last twelve months to 2.16T, up 11.23% year-over-year. In the year 2023, Imexpharm had annual revenue of 1.99T with 21.31% growth.

• Revenue (ttm): 2,161.21B
• Revenue Growth: +11.23%
• P/S Ratio: 2.98
• Revenue / Employee: 1.49B
• Employees: 1,415
• Market Cap: 6,437.57B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1,994.04B	350.33B	21.31%
Dec 31, 2022	1,643.71B	377.11B	29.77%
Dec 31, 2021	1,266.60B	-102.83B	-7.51%
Dec 31, 2020	1,369.42B	-33.03B	-2.36%
Dec 31, 2019	1,402.45B	217.64B	18.37%